Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-09	Matthew Young, Ph.D.
Wong, David T	University Of California Los Angeles United States	EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment	4U01CA233370-08	Nicholas Hodges, Ph.D.
Wright, Alexi A	Dana-Farber Cancer Inst United States	Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors	5R01CA289547-02	Goli Samimi, Ph.D., M.P.H.
Wu, Yun	State University Of New York At Buffalo United States	Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay	4R01CA272827-04	Christos Patriotis, Ph.D., M.Sc.
Xiao, Yi	University Of Tx Md Anderson Can Ctr United States	Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1	5R21CA286318-02	Anda Vlad, M.D., Ph.D.
Xu, Xiangxi Mike	University Of Miami School Of Medicine United States	Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy	5R01CA286527-02	Rachel Altshuler, Ph.D.
Xu, Chunhui	Emory University United States	High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes	1R21CA285254-01A1	Eileen Dimond, R.N., M.S.
Yaddanapudi, Kavitha	University Of Louisville United States	A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer	5R21CA277314-02
Yaghjyan, Lusine	University Of Florida United States	Stromal contributions to breast carcinogenesis	5R01CA277817-03	Christos Patriotis, Ph.D., M.Sc.
Yang, Wan	Columbia University Health Sciences United States	UNCOVER: underlying novel causes of onset of very early cancer research	5R01CA257971-05	Nicholas Hodges, Ph.D.
Yang, Qing	University Of Texas Med Br Galveston United States	The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy	5R01CA273001-02	Rachel Altshuler, Ph.D.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-04	Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna	Roswell Park Cancer Institute Corp United States	Metformin for chemoprevention of lung cancer in obese subjects at high risk	5R01CA255515-05	Malgorzata Wojtowicz, M.D.
Yilmaz, Omer	Massachusetts Institute Of Technology United States	PROSPECT - Stem cell models	3OT2CA297570-01S1	Asad Umar, D.V.M., Ph.D.
You, Ming	Methodist Hospital Research Institute United States	Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis	5R01CA280746-02	John Clifford, Ph.D.